结肠癌术后辅助化疗
摘要
结肠癌是临床最常见的恶性肿瘤之一.在美国,结肠癌发病率占所有癌症的第4位,而病死率为第2位.2011年美国约有101340例结肠癌和39870例直肠癌的新发病例;而同年估计将有49380例患者死于结肠癌.我国近年来结肠癌在普通人群中的发病率也有逐渐增高的趋势,达到年均4%.
出处
《中国现代普通外科进展》
CAS
2014年第8期668-670,共3页
Chinese Journal of Current Advances in General Surgery
参考文献25
-
1Jemal A,Siegel R,Xu J,et al.Cancer statistics,2010[J].CA Cancer J Clin,2010,60(5):277-300.
-
2聂绍发,姚漩,朱桂荣,等武汉市大肠癌危险因素的2:3配比病例对照研究[J].中国公共卫生,2003,29(23):2593-2595.
-
3何友兼,董秋美,李宇红.结肠癌全身辅助化疗的进展[J].癌症,2005,24(12):1546-1549. 被引量:13
-
4O'Connell M J,Sargent DJ,Windschitl HE,et al.Randomized clinical trial of high-dose levamisole combined with 5-fluorouracil and leucovorin as surgical adjuvant therapy for high-risk colon cancer[J].Clin Colorectal Cancer,2006,6(2):133-139.
-
5Twelves C,Wong A,Nowacki MP,et al.Capecitabine as adjuvant treatment for stage Ⅲ colon cancer[J].N Engl J Med,2005,352(26):2696-2704.
-
6Poplin EA,Benedetti JK,Estes NC,et al.Phase Ⅲ Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil,leucovorin and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage Ⅲ and high-risk stage Ⅱ colon cancer[J].J Clin Oncol,2005,23(9):1819-1825.
-
7Andre T,Boni C,Mounedji-Boudiaf L,et al.Oxaliplatin,fluorouracil and leucovorin as adjuvant treatment for colon cancer[J].N Engl J Med,2004,350 (23):2343-2351.
-
8Gill S,Loprinzi CL,Sargent DJ,et al.Pooled analysis of fluorouracilbased adjuvant therapy for stage Ⅱ and Ⅲ colon cancer:who benefits and by how much[J].J Clin Oncol,2004,22(10):1797-1806.
-
9Cascinu S,Catalano V,Piga A,et al.The role of levamisole in the adjuvant treatment of stage Ⅲ colon cancer patients:a randomized trial?of 5-fluorouracil and levamisole versus 5-fluorouracil alone[J].Cancer Invest,2003,21 (5):701-707.
-
10Andre T,Colin P,Louver C,et al.Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage Ⅱ and Ⅲ colon cancer:results of a randomized trial[J].J Clin Oncol,2003,21 (15):2896-2903.
二级参考文献36
-
1李连弟,鲁凤珠.1990—1992年中国恶性肿瘤死亡流行分布情况分析[J].中华肿瘤杂志,1996,18(6):403-407. 被引量:227
-
2张天泽 徐光炜.肿瘤学[M].天津:天津科学技术出版社,1996.1209.
-
3汤钊猷.现代肿瘤学[M].上海:上海医科大学出版社,1994.676.
-
4Buyse M, Zeleniuch-Jacquotte A,Chalmers TC. Adjuvant therapy of colorectal cancer. Why we still don't know? [J]. JAMA, 1988,259(24):3571-3578.
-
5Wolmark N, Fisher B, Rockette H, et al. Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01 [J]. J Natl Cancer Inst, 1988,80( 1 ): 30-36.
-
6Laurie JA, Moertel CG, Fleming TR,et al. Surgical adjuvant therapy of largebowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic [J]. J Clin Oncol,1989,7(10): 1447-1456.
-
7Moertel CG, Fleming TR, Macdonald JS, et al. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage Ⅲ colon carcinoma:a final report [J]. Ann Intern Med,1995,122(5) :321-326.
-
8Wolmark N, Rockette H, Fisher B, et al. The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer:results from National Surgical Adjuvant Breast and Bowel Project protocol C-03[J]. J Clin Oncol, 1993,11 (10): 1879-1887.
-
9O'Connell MJ, Mailliard JA, Kahn MJ,et al. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer [J]. J Clin Oncol, 1997,15( 1 ) :246-250.
-
10Efficacy of adjuvant fluorouracil and folinic acid in colon cancer.International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators [J]. Lancet,1995,345 (8955): 939-944.
共引文献19
-
1肖志异.结肠癌患者术后辅助化疗的临床分析[J].现代养生,2014,0(6):128-129.
-
2江国斌,徐东,曹飞麟,蔡建明.两种化疗方案治疗晚期初治大肠癌的比较[J].江西医药,2006,41(6):387-389. 被引量:1
-
3马海英,赵宏,焦顺昌,史宏刚,王志强,司海燕.高聚生联合化疗治疗结肠癌的近期疗效观察[J].中国肿瘤临床,2006,33(18):1058-1060. 被引量:2
-
4李悦,于雁.奥沙利铂联合氟尿嘧啶、亚叶酸钙联合治疗晚期消化道癌临床疗效分析[J].实用肿瘤学杂志,2006,20(6):525-526. 被引量:4
-
5寸英丽,代佑果,马骏,查勇,张麒,张文.阿贝奇诺治疗大肠癌化疗毒副反应60例[J].中国肿瘤,2007,16(2):139-140. 被引量:3
-
6刘海荣,李岩,梁婧.伊立替康对结肠癌Th1和Th2类细胞因子的影响[J].临床肿瘤学杂志,2007,12(4):267-270. 被引量:3
-
7宫媛,吴本俨.循证医学评价结肠癌辅助化疗药物及新进展[J].中国新药杂志,2007,16(10):757-761. 被引量:7
-
8陈建平,高春芳,马贵义.大肠癌治疗进展[J].实用医药杂志,2008,25(2):232-234. 被引量:13
-
9秦光远,黄桂林,邵建强,郭清江.大肠癌的治疗进展[J].医学综述,2009,15(1):58-60. 被引量:11
-
10解亦斌,刘方伶,田艳涛,王成锋,单毅,赵东兵,赵平.升结肠癌跳跃式转移至右颈部及左腋下淋巴结1例分析[J].中国肿瘤临床,2009,36(10):593-596. 被引量:4
-
1廖爱民.低位直肠腺癌局部切除术[J].中国中医药咨讯,2012,4(6):132-132.
-
2Malo.,KE,柳满然.普通人群BRCA1基因突变与乳腺癌的关系:对年龄不足35岁 …[J].美国医学会杂志(中文版),1999,18(2):74-79.
-
3李明,吴斌,宋永胜,霍军,殷波,费翔,郭启振,韩斌,郭恩忠,卜仁戈.肾上腺神经鞘瘤临床分析[J].现代肿瘤医学,2014,22(11):2666-2668. 被引量:1
-
4李建华,王华,宋丰贵.老年人肺癌临床特征及诊疗技术的研究进展[J].中国老年学杂志,2009,29(21):2839-2842. 被引量:3
-
5鲁群.原发性胆囊癌18例临床分析[J].九江医学,1998,13(1):22-23.
-
6王共先,傅龙龙.激素非依赖性前列腺癌分子靶向治疗研究进展[J].现代泌尿生殖肿瘤杂志,2011,3(6):321-323. 被引量:1
-
7沈华才.肾癌125例诊治体会[J].南通医学院学报,2001,21(1):79-80. 被引量:1
-
8石银珍.细胞凋亡与乳腺癌的发生和治疗研究进展[J].中国肿瘤临床与康复,2001,8(5):117-118. 被引量:2
-
9张振宙,王柳英,赵永红,赵凤兰.直肠类癌14例临床分析[J].包头医学,2009,33(3):140-142.
-
10何明学,李油山,王敏,任万武.肺硬化性血管瘤5例及文献复习[J].华西医学,2008,23(5).